New Delhi: With a manufacturing capacity of 850 million doses in India, Sputnik V, if approved, will prove to be a big shot in the arm in the fight against coronaviruses of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia’s Sputnik V. Obtain for Emergency Use Authority (EUA) in India.
India may receive a third COVID-19 vaccine soon to consider the Sputnik V application for the Emergency Use Authority (EUA) in India as the Subject Expert Committee (SEC) will meet on Monday 12 April.
As more and more states lack a dose of the coronovirus vaccine, the center has pressed the accelerator to increase the vaccine by leaps and bounds.